Cheaper CAR T in the works

Posted 23 July 2024 AM

New technology being developed at the University of South Australia (UniSA) could overcome the CAR T-cell therapy bottleneck and cut costs by up to 14 per cent.

The research team's work, partly funded by Carina Biotech, has shown the potential of a microfluidic technology called inertial spiral microfluidics to improve CAR T-cell manufacturing process by efficiently removing contaminating cancerous cells and other large white blood cells.

To see the whole article, please login